Assessing the Clinical Benefit and Quality of Life of Psychotropic Medication Among Adults with Neurogenic Features of Rosacea: A Systematic Review
Published: 9 September 2026| Version 1 | DOI: 10.17632/jckscdpnw3.1
Contributor:
Taylor JazrawiDescription
Supplemental material for Assessing the Clinical Benefit and Quality of Life of Psychotropic Medication Among Adults with Neurogenic Features of Rosacea: A Systematic Review. Supplemental materials include characteristics of selected studies, summary of clinical benefit of neuromodulator and vasoactive medications in rosacea, database search strategies, and study methodology.
Files
Categories
Psychotropic Drug, Beta-Blocker, Rosacea, Systematic Review, Quality of Life